C
1.43
0.01 (0.70%)
| Penutupan Terdahulu | 1.42 |
| Jumlah Dagangan | 314,379 |
| Harga / Buku (P/B) | 0.830 |
| Julat 52 Minggu |
| Margin Keuntungan | -200.58% |
| Margin Operasi (TTM) | -276.55% |
| EPS Cair (TTM) | -2.17 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -18.30% |
| Nisbah Semasa (MRQ) | 9.78 |
| Aliran Tunai Operasi (OCF TTM) | -19.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.99 M |
| Pulangan Atas Aset (ROA TTM) | -56.19% |
| Pulangan Atas Ekuiti (ROE TTM) | -93.42% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | CervoMed Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | -1.7 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -1.7 |
| Masa 35% | -1.5 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | 0.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -17.9% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 1.4 |
| Skor Akhir | -1.70 |
|
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 33.38% |
| % Dimiliki oleh Institusi | 26.31% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Thompson Davis & Co., Inc. | 30 Sep 2026 | 25,900 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |